Cyclooxygenase-2-prostaglandin e2-eicosanoid receptor inflammatory axis: A key player in Kaposi's sarcoma-associated herpes virus associated malignancies

Translational Research

Volumn 162, Issue 2, 2013, Pages 77-92

  Paul, Arun George ^a   Chandran, Bala ^a   Sharma Walia, Neelam ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 ISOPROPOXY 9 OXO 2 XANTHENECARBOXYLIC ACID; 7 [5 (4 BIPHENYLYLMETHOXY) 2 MORPHOLINO 3 OXOCYCLOPENTYL] 4 HEPTENOIC ACID; 8 CHLORO N2 [3 (FURFURYLTHIO)PROPIONYL]DIBENZ[B,F][1,4]OXAZEPINE 10(11H) CARBOHYDRAZIDE; ARACHIDONIC ACID; CD30 ANTIGEN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; EICOSANOID RECEPTOR; EICOSANOID RECEPTOR 1; EICOSANOID RECEPTOR 2; EICOSANOID RECEPTOR 3; EICOSANOID RECEPTOR 4; FAS ANTIGEN; INTERLEUKIN 6; LATENCY ASSOCIATED NUCLEAR ANTIGEN; LATENCY ASSOCIATED NUCLEAR ANTIGEN 1; LEUKOTRIENE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTAGLANDIN E2; PROSTAGLANDIN E2 DERIVATIVE; PROSTAGLANDIN H2; PROSTANOID RECEPTOR; SYNDECAN 1; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN; VFLIP PROTEIN; VIRUS PROTEIN;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CANCER PROGNOSIS; CELL ADHESION; CELL CYCLE REGULATION; CELL INVASION; CELL PROLIFERATION; CELL TRANSFORMATION; DRUG POTENCY; GENE EXPRESSION; HERPES VIRUS INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN HERPESVIRUS 8; INFLAMMATION; KAPOSI SARCOMA; LIFE CYCLE; NEOPLASM; NONHUMAN; PARACRINE SIGNALING; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; VIRUS LATENCY; VIRUS PATHOGENESIS; VIRUS STRAIN;

EID: 84880571879     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2013.03.004     Document Type: Review

References (198)

1. S.I. Grivennikov, F.R. Greten, and M. Karin Immunity, inflammation, and cancer Cell 140 2010 883 899
2. S. Rakoff-Nahoum Why cancer and inflammation? Yale J Biol Med 79 2006 123 130
3. L.M. Coussens, and Z. Werb Inflammation and cancer Nature 420 2002 860 867
4. F. Balkwill, and A. Mantovani Inflammation and cancer: back to Virchow? Lancet 357 2001 539 545
5. D. Wang, and R.N. Dubois Prostaglandins and cancer Gut 55 2006 115 122
6. J.G. Sinkovics Molecular biology of oncogenic inflammatory processes. I. Nononcogenic and oncogenic pathogens, intrinsic inflammatory reactions without pathogens, and microRNA/DNA interactions (Review) Int J Oncol 40 2012 305 349
7. J.K. Kundu, and Y.J. Surh Inflammation: gearing the journey to cancer Mutat Res 659 2008 15 30
8. A. Mantovani, P. Allavena, A. Sica, and F. Balkwill Cancer-related inflammation Nature 454 2008 436 444
9. G.S. Taylor, and D.J. Blackbourn Infectious agents in human cancers: lessons in immunity and immunomodulation from gammaherpesviruses EBV and KSHV Cancer Lett 305 2011 263 278
10. D. Martin, and J.S. Gutkind Human tumor-associated viruses and new insights into the molecular mechanisms of cancer Oncogene 27 Suppl 2 2008 S31 S42
11. A. Saha, R. Kaul, M. Murakami, and E.S. Robertson Tumor viruses and cancer biology: modulating signaling pathways for therapeutic intervention Cancer Biol Ther 10 2010 961 978
12. N.R. Cooper, and G.R. Nemerow Complement and infectious agents: a tale of disguise and deception Complement Inflamm 6 1989 249 258
13. N.V. Chandrasekharan, and D.L. Simmons The cyclooxygenases Genome Biol 5 2004 241
14. J. Cuzick, F. Otto, and J.A. Baron Aspirin and nonsteroidal anti-inflammatory drugs for cancer prevention: an international consensus statement Lancet Oncol 10 2009 501 507
15. Y.S. Bakhle COX-2 and cancer: a new approach to an old problem Br J Pharmacol 134 2001 1137 1150
16. S. Zha, V. Yegnasubramanian, W.G. Nelson, W.B. Isaacs, and A.M. De Marzo Cyclooxygenases in cancer: progress and perspective Cancer Lett 215 2004 1 20
17. M. Ladetto, S. Vallet, and A. Trojan Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome Blood 105 2005 4784 4791
18. M.P. Bernard, S. Bancos, P.J. Sime, and R.P. Phipps Targeting cyclooxygenase-2 in hematological malignancies: rationale and promise Curr Pharm Des 14 2008 2051 2060
19. D. Wang, and R.N. Dubois Eicosanoids and cancer Nat Rev Cancer 10 2010 181 193
20. F.A. Fitzpatrick, R. Aguirre, J.E. Pike, and F.H. Lincoln The stability of 13,14-dihydro-15 keto-PGE2 Prostaglandins 19 1980 917 931
21. Y. Sugimoto, and S. Narumiya Prostaglandin E receptors J Biol Chem 282 2007 11613 11617
22. K.M. Ansari, J.E. Rundhaug, and S.M. Fischer Multiple signaling pathways are responsible for prostaglandin E2-induced murine keratinocyte proliferation Mol Cancer Res 6 2008 1003 1016
23. B. Poligone, and A.S. Baldwin Positive and negative regulation of NF-κB by COX-2: roles of different prostaglandins J Biol Chem 276 2001 38658 38664
24. D. Wang, and R.N. DuBois Proinflammatory prostaglandins and progression of colorectal cancer Cancer Lett 267 2008 197 203
25. M. Casibang, and T.W. Moody AH6809 antagonizes nonsmall cell lung cancer prostaglandin receptors Lung Cancer 36 2002 33 42
26. A.M. Fulton, X. Ma, and N. Kundu Targeting prostaglandin E EP receptors to inhibit metastasis Cancer Res 66 2006 9794 9797
27. M. Majima, H. Amano, and I. Hayashi Prostanoid receptor signaling relevant to tumor growth and angiogenesis Trends Pharmacol Sci 24 2003 524 529
28. E. Lara-Pezzi, M.V. Gomez-Gaviro, and B.G. Galvez The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression J Clin Invest 110 2002 1831 1838
29. W. Lim, S.H. Kwon, and H. Cho HBx targeting to mitochondria and ROS generation are necessary but insufficient for HBV-induced cyclooxygenase-2 expression J Mol Med (Berl) 88 2011 359 369
30. G. Waris, and A. Siddiqui Hepatitis C virus stimulates the expression of cyclooxygenase-2 via oxidative stress: role of prostaglandin E2 in RNA replication J Virol 79 2005 9725 9734
31. M.E. Janelle, A. Gravel, J. Gosselin, M.J. Tremblay, and L. Flamand Activation of monocyte cyclooxygenase-2 gene expression by human herpesvirus 6. Role for cyclic AMP-responsive element-binding protein and activator protein-1 J Biol Chem 277 2002 30665 30674
32. M.A. Nokta, M.I. Hassan, K. Loesch, and R.B. Pollard Human cytomegalovirus-induced immunosuppression. Relationship to tumor necrosis factor-dependent release of arachidonic acid and prostaglandin E2 in human monocytes J Clin Invest 97 1996 2635 2641
33. E. Speir, Z.X. Yu, V.J. Ferrans, E.S. Huang, and S.E. Epstein Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells Circ Res 83 1998 210 216
34. H. Zhu, J.P. Cong, D. Yu, W.A. Bresnahan, and T.E. Shenk Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication Proc Natl Acad Sci U S A 99 2002 3932 3937
35. J. Schroer, and T. Shenk Inhibition of cyclooxygenase activity blocks cell-to-cell spread of human cytomegalovirus Proc Natl Acad Sci U S A 105 2008 19468 19473
36. T.L. Symensma, D. Martinez-Guzman, and Q. Jia COX-2 induction during murine gammaherpesvirus 68 infection leads to enhancement of viral gene expression J Virol 77 2003 12753 12763
37. L.M. Wahl, M.L. Corcoran, S.W. Pyle, L.O. Arthur, A. Harel-Bellan, and W.L. Farrar Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1 Proc Natl Acad Sci U S A 86 1989 621 625
38. P. Foley, F. Kazazi, R. Biti, T.C. Sorrell, and A.L. Cunningham HIV infection of monocytes inhibits the T-lymphocyte proliferative response to recall antigens, via production of eicosanoids Immunology 75 1992 391 397
39. M. Moriuchi, H. Inoue, and H. Moriuchi Reciprocal interactions between human T-lymphotropic virus type 1 and prostaglandins: implications for viral transmission J Virol 75 2001 192 198
40. L. Liu, R. Li, and Y. Pan High-throughput screen of protein expression levels induced by cyclooxygenase-2 during influenza a virus infection Clin Chim Acta 412 2011 1081 1085
41. W.H. Tung, H.L. Hsieh, I.T. Lee, and C.M. Yang Enterovirus 71 modulates a COX-2/PGE2/cAMP-dependent viral replication in human neuroblastoma cells: role of the c-Src/EGFR/p42/p44 MAPK/CREB signaling pathway J Cell Biochem 112 2011 559 570
42. W.L. Wu, L.J. Ho, D.M. Chang, C.H. Chen, and J.H. Lai Triggering of DC migration by dengue virus stimulation of COX-2-dependent signaling cascades in vitro highlights the significance of these cascades beyond inflammation Eur J Immunol 39 2009 3413 3422
43. X. Yan, Q. Hao, and Y. Mu Nucleocapsid protein of SARS-CoV activates the expression of cyclooxygenase-2 by binding directly to regulatory elements for nuclear factor-kappa B and CCAAT/enhancer binding protein Int J Biochem Cell Biol 38 2006 1417 1428
44. E. Molina-Holgado, A. Arevalo-Martin, S. Ortiz, J.M. Vela, and C. Guaza Theiler's virus infection induces the expression of cyclooxygenase-2 in murine astrocytes: inhibition by the anti-inflammatory cytokines interleukin-4 and interleukin-10 Neurosci Lett 324 2002 237 241
45. S.A. Steer, and J.A. Corbett The role and regulation of COX-2 during viral infection Viral Immunol 16 2003 447 460
46. S.A. Steer, J.M. Moran, B.S. Christmann, L.B. Maggi Jr., and J.A. Corbett Role of MAPK in the regulation of double-stranded RNA- and encephalomyocarditis virus-induced cyclooxygenase-2 expression by macrophages J Immunol 177 2006 3413 3420
47. A. Henke, H.P. Spengler, A. Stelzner, M. Nain, and D. Gemsa Lipopolysaccharide suppresses cytokine release from coxsackie virus-infected human monocytes Res Immunol 143 1992 65 70
48. H. Bartz, F. Buning-Pfaue, O. Turkel, and U. Schauer Respiratory syncytial virus induces prostaglandin E2, IL-10 and IL-11 generation in antigen presenting cells Clin Exp Immunol 129 2002 438 445
49. S. Krakowka, S.S. Ringler, M. Lewis, R.G. Olsen, and M.K. Axthelm Immunosuppression by canine distemper virus: modulation of in vitro immunoglobulin synthesis, interleukin release and prostaglandin E2 production Vet Immunol Immunopathol 15 1987 181 201
50. A.E. Reynolds, and L.W. Enquist Biological interactions between herpesviruses and cyclooxygenase enzymes Rev Med Virol 16 2006 393 403
51. C.A. Rue, M.A. Jarvis, and A.J. Knoche A cyclooxygenase-2 homologue encoded by rhesus cytomegalovirus is a determinant for endothelial cell tropism J Virol 78 2004 12529 12536
52. R. Kaul, S.C. Verma, M. Murakami, K. Lan, T. Choudhuri, and E.S. Robertson Epstein-Barr virus protein can upregulate cyclo-oxygenase-2 expression through association with the suppressor of metastasis Nm23-H1 J Virol 80 2006 1321 1331
53. S. Murono, H. Inoue, and T. Tanabe Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells Proc Natl Acad Sci U S A 98 2001 6905 6910
54. A.K. Lo, K.W. Lo, and S.W. Tsao Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells Neoplasia 8 2006 173 180
55. J.J. Hooks, M.S. Chin, and K. Srinivasan Human cytomegalovirus induced cyclooxygenase-2 in human retinal pigment epithelial cells augments viral replication through a prostaglandin pathway Microbes Infect 8 2006 2236 2244
56. S. Higaki, K. Watanabe, M. Itahashi, and Y. Shimomura Cyclooxygenase (COX)-inhibiting drug reduces HSV-1 reactivation in the mouse eye model Curr Eye Res 34 2009 171 176
57. B.M. Gebhardt, E.D. Varnell, and H.E. Kaufman Inhibition of cyclooxygenase 2 synthesis suppresses Herpes simplex virus type 1 reactivation J Ocul Pharmacol Ther 21 2005 114 120
58. M. Savard, C. Belanger, and M.J. Tremblay EBV suppresses prostaglandin E2 biosynthesis in human monocytes J Immunol 164 2000 6467 6473
59. N. Sharma-Walia, A.G. Paul, and V. Bottero Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion PLoS Pathog 6 2010 e1000777
60. N. Sharma-Walia, A.G. Paul, and K. Patel NFAT and CREB regulate Kaposi's sarcoma associated herpes virus (KSHV) induced cyclooxygenase-2 (Cox-2) J Virol 84 2010 12733 12753
61. N. Sharma-Walia, H. Raghu, and S. Sadagopan Cyclooxygenase 2 induced by Kaposi's sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression J Virol 80 2006 6534 6552
62. G.A. Paul, N. Sharma-Walia, N. Kerur, C. White, and B. Chandran Piracy of prostaglandin E2/EP receptor-mediated signaling by Kaposi's sarcoma-associated herpes virus (HHV-8) for latency gene expression: strategy of a successful pathogen Cancer Res 70 2010 3697 3708
63. A.G. Paul, N. Sharma-Walia, and B. Chandran Targeting KSHV/HHV-8 latency with COX-2 selective inhibitor nimesulide: a potential chemotherapeutic modality for primary effusion lymphoma PLoS One 6 2011 e24379
64. N. Sharma-Walia, K. Patel, and K. Chandran COX-2/PGE2: molecular ambassadors of Kaposi's sarcoma-associated herpes virus oncoprotein-vFLIP Oncogenesis 1 2012 e5
65. A.G. Paul, B. Chandran, and N. Sharma-Walia Concurrent targeting of EP1/EP4 receptors and COX-2 induces synergistic apoptosis in KSHV and EBV associated non-Hodgkin lymphoma cell lines Transl Res 2013 doi:pii: S1931-5244(13)00070-4
66. D.V. Ablashi, L.G. Chatlynne, J.E. Whitman Jr., and E. Cesarman Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases Clin Microbiol Rev 15 2002 439 464
67. A. Carbone, and A. Gloghini HHV-8-associated lymphoma: state-of-the-art review Acta Haematol 117 2007 129 131
68. E. Cesarman, Y. Chang, P.S. Moore, J.W. Said, and D.M. Knowles Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas N Engl J Med 332 1995 1186 1191
69. U. Klein, A. Gloghini, and G. Gaidano Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts Blood 101 2003 4115 4121
70. D. Ganem KSHV infection and the pathogenesis of Kaposi's sarcoma Annu Rev Pathol 1 2006 273 296
71. M. Bower, C. Palmieri, and T. Dhillon AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy Curr Opin Infect Dis 19 2006 14 19
72. D.P. Dittmer Restricted Kaposi's sarcoma (KS) herpesvirus transcription in KS lesions from patients on successful antiretroviral therapy MBio 2 2011 e00138-11
73. F.H. Cox, and E.B. Helwig Kaposi's sarcoma Cancer 12 1959 289 298
74. Y. Chang, E. Cesarman, and M.S. Pessin Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma Science 266 1994 1865 1869
75. P.S. Moore, and Y. Chang Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection N Engl J Med 332 1995 1181 1185
76. R. Sarid, J.S. Wiezorek, P.S. Moore, and Y. Chang Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter J Virol 73 1999 1438 1446
77. A. Carbone, E. Cesarman, M. Spina, A. Gloghini, and T.F. Schulz HIV-associated lymphomas and gamma-herpesviruses Blood 113 2009 1213 1224
78. A. Zaman, M.H. Rahaman, and S. Razzaque Kaposi's sarcoma: a computational approach through protein-protein interaction and gene regulatory networks analysis Virus Genes 46 2013 242 254
79. E.A. Mesri, E. Cesarman, and C. Boshoff Kaposi's sarcoma and its associated herpesvirus Nat Rev Cancer 10 2010 707 719
80. Q. Cai, S.C. Verma, J. Lu, and E.S. Robertson Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis Adv Virus Res 78 2010 87 142
81. K.W. Wen, and B. Damania Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis Cancer Lett 289 2010 140 150
82. P.P. Naranatt, H.H. Krishnan, S.R. Svojanovsky, C. Bloomer, S. Mathur, and B. Chandran Host gene induction and transcriptional reprogramming in Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8)-infected endothelial, fibroblast, and B cells: insights into modulation events early during infection Cancer Res 64 2004 72 84
83. R.E. Harris Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer Subcell Biochem 42 2007 93 126
84. P.P. Naranatt, S.M. Akula, C.A. Zien, H.H. Krishnan, and B. Chandran Kaposi's sarcoma-associated herpesvirus induces the phosphatidylinositol 3-kinase-PKC-zeta-MEK-ERK signaling pathway in target cells early during infection: implications for infectivity J Virol 77 2003 1524 1539
85. N. Sharma-Walia, H.H. Krishnan, P.P. Naranatt, L. Zeng, M.S. Smith, and B. Chandran ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection J Virol 79 2005 10308 10329
86. N. Sharma-Walia, P.P. Naranatt, H.H. Krishnan, L. Zeng, and B. Chandran Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 envelope glycoprotein gB induces the integrin-dependent focal adhesion kinase-Src-phosphatidylinositol 3-kinase-rho GTPase signal pathways and cytoskeletal rearrangements J Virol 78 2004 4207 4223
87. P.P. Naranatt, H.H. Krishnan, M.S. Smith, and B. Chandran Kaposi's sarcoma-associated herpesvirus modulates microtubule dynamics via RhoA-GTP-diaphanous 2 signaling and utilizes the dynein motors to deliver its DNA to the nucleus J Virol 79 2005 1191 1206
88. M.V. Veettil, N. Sharma-Walia, and S. Sadagopan RhoA-GTPase facilitates entry of Kaposi's sarcoma-associated herpesvirus into adherent target cells in a Src-dependent manner J Virol 80 2006 11432 11446
89. S. Sadagopan, N. Sharma-Walia, and M.V. Veettil Kaposi's sarcoma-associated herpesvirus induces sustained NF-κB activation during de novo infection of primary human dermal microvascular endothelial cells that is essential for viral gene expression J Virol 81 2007 3949 3968
90. H.H. Krishnan, N. Sharma-Walia, D.N. Streblow, P.P. Naranatt, and B. Chandran Focal adhesion kinase is critical for entry of Kaposi's sarcoma-associated herpesvirus into target cells J Virol 80 2006 1167 1180
91. R. Sivakumar, N. Sharma-Walia, and H. Raghu Kaposi's sarcoma-associated herpesvirus induces sustained levels of vascular endothelial growth factors A and C early during in vitro infection of human microvascular dermal endothelial cells: biological implications J Virol 82 2008 1759 1776
92. H. Raghu, N. Sharma-Walia, and M.V. Veettil Lipid rafts of primary endothelial cells are essential for Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8-induced phosphatidylinositol 3-kinase and RhoA-GTPases critical for microtubule dynamics and nuclear delivery of viral DNA but dispensable for binding and entry J Virol 81 2007 7941 7959
93. H. Moriuchi, and M. Moriuchi In vitro induction of HIV-1 replication in resting CD4(+) T cells derived from individuals with undetectable plasma viremia upon stimulation with human T-cell leukemia virus type I Virology 278 2000 514 519
94. V. Punj, H. Matta, S. Schamus, and P.M. Chaudhary Integrated microarray and multiplex cytokine analyses of Kaposi's Sarcoma Associated Herpesvirus viral FLICE Inhibitory Protein K13 affected genes and cytokines in human blood vascular endothelial cells BMC Med Genomics 2 2009 50
95. S. Sakakibara, C.A. Pise-Masison, J.N. Brady, and G. Tosato Gene regulation and functional alterations induced by Kaposi's sarcoma-associated herpesvirus-encoded ORFK13/vFLIP in endothelial cells J Virol 83 2009 2140 2153
96. B.D. Shelby, H.L. LaMarca, and H.E. McFerrin Kaposi's sarcoma associated herpesvirus G-protein coupled receptor activation of cyclooxygenase-2 in vascular endothelial cells Virol J 4 2007 87
97. M.M. Brinkmann, M. Pietrek, O. Dittrich-Breiholz, M. Kracht, and T.F. Schulz Modulation of host gene expression by the K15 protein of Kaposi's sarcoma-associated herpesvirus J Virol 81 2007 42 58
98. B. Chandran Early events in Kaposi's sarcoma-associated herpesvirus infection of target cells J Virol 84 2010 2188 2199
99. S. Dupuy, M. Lambert, and D. Zucman Human Herpesvirus 8 (HHV8) sequentially shapes the NK cell repertoire during the course of asymptomatic infection and Kaposi sarcoma PLoS Pathog 8 2012 e1002486
100. D. Qin, Y. Zeng, and C. Qian Induction of lytic cycle replication of Kaposi's sarcoma-associated herpesvirus by herpes simplex virus type 1: involvement of IL-10 and IL-4 Cell Microbiol 10 2008 713 728
101. M.R. Staudt, Y. Kanan, J.H. Jeong, J.F. Papin, R. Hines-Boykin, and D.P. Dittmer The tumor microenvironment controls primary effusion lymphoma growth in vivo Cancer Res 64 2004 4790 4799
102. S.C. Verma, K. Lan, and E. Robertson Structure and function of latency-associated nuclear antigen Curr Top Microbiol Immunol 312 2007 101 136
103. Q. Sun, H. Matta, G. Lu, and P.M. Chaudhary Induction of IL-8 expression by human herpesvirus 8 encoded vFLIP K13 via NF-kappaB activation Oncogene 25 2006 2717 2726
104. C. Grossmann, S. Podgrabinska, M. Skobe, and D. Ganem Activation of NF-kappaB by the latent vFLIP gene of Kaposi's sarcoma-associated herpesvirus is required for the spindle shape of virus-infected endothelial cells and contributes to their proinflammatory phenotype J Virol 80 2006 7179 7185
105. H. Matta, R. Gopalakrishnan, and C. Graham Kaposi's sarcoma associated herpesvirus encoded viral FLICE inhibitory protein K13 activates NF-kappaB pathway independent of TRAF6, TAK1 and LUBAC PLoS One 7 2012 e36601
106. V. Punj, H. Matta, S. Schamus, T. Yang, Y. Chang, and P.M. Chaudhary Induction of CCL20 production by Kaposi sarcoma-associated herpesvirus: role of viral FLICE inhibitory protein K13-induced NF-kappaB activation Blood 113 2009 5660 5668
107. P. Chugh, H. Matta, and S. Schamus Constitutive NF-kappaB activation, normal Fas-induced apoptosis, and increased incidence of lymphoma in human herpes virus 8 K13 transgenic mice Proc Natl Acad Sci U S A 102 2005 12885 12890
108. Q. Sun, H. Matta, and P.M. Chaudhary The human herpes virus 8-encoded viral FLICE inhibitory protein protects against growth factor withdrawal-induced apoptosis via NF-kappa B activation Blood 101 2003 1956 1961
109. I. Guasparri, H. Wu, and E. Cesarman The KSHV oncoprotein vFLIP contains a TRAF-interacting motif and requires TRAF2 and TRAF3 for signalling EMBO Rep 7 2006 114 119
110. J. Friborg Jr., W. Kong, M.O. Hottiger, and G.J. Nabel p53 inhibition by the LANA protein of KSHV protects against cell death Nature 402 1999 889 894
111. J.S. Lee, Q. Li, and J.Y. Lee FLIP-mediated autophagy regulation in cell death control Nat Cell Biol 11 2009 1355 1362
112. M. Fujimuro, F.Y. Wu, and C. ApRhys A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency Nat Med 9 2003 300 306
113. C.M. Klass, and M.K. Offermann Targeting human herpesvirus-8 for treatment of Kaposi's sarcoma and primary effusion lymphoma Curr Opin Oncol 17 2005 447 455
114. F. Curreli, A.E. Friedman-Kien, and O. Flore Glycyrrhizic acid alters Kaposi sarcoma-associated herpesvirus latency, triggering p53-mediated apoptosis in transformed B lymphocytes J Clin Invest 115 2005 642 652
115. H.G. Drexler, C. Meyer, G. Gaidano, and A. Carbone Constitutive cytokine production by primary effusion (body cavity-based) lymphoma-derived cell lines Leukemia 13 1999 634 640
116. M.K. Jones, H. Wang, and B.M. Peskar Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing Nat Med 5 1999 1418 1423
117. O. Dormond, A. Foletti, C. Paroz, and C. Ruegg NSAIDs inhibit alpha V beta 3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis Nat Med 7 2001 1041 1047
118. D.J. de Groot, M. van der Deen, T.K. Le, A. Regeling, S. de Jong, and E.G. de Vries Indomethacin induces apoptosis via a MRP1-dependent mechanism in doxorubicin-resistant small-cell lung cancer cells overexpressing MRP1 Br J Cancer 97 2007 1077 1083
119. M. Kaur Saini, J. Kaur, P. Sharma, and S. Nath Sanyal Chemopreventive response of diclofenac, a nonsteroidal anti-inflammatory drug in experimental carcinogenesis Nutr Hosp 24 2009 717 723
120. J.F. Liu, G.J. Zhu, and G.G. Jamieson NS-398 induces apoptosis in human esophageal cancer cells through inhibition of NF-kappaB downstream regulation of cyclooxygenase-2 Cancer Invest 27 2009 17 23
121. J.F. Renard, F. Julemont, X. de Leval, and B. Pirotte The use of nimesulide and its analogues in cancer chemoprevention Anticancer Agents Med Chem 6 2006 233 237
122. M.A. Hull Cyclooxygenase-2: how good is it as a target for cancer chemoprevention? Eur J Cancer 41 2005 1854 1863
123. J.M. Bock, S.G. Menon, and L.L. Sinclair Celecoxib toxicity is cell cycle phase specific Cancer Res 67 2007 3801 3808
124. B. Everts, P. Wahrborg, and T. Hedner COX-2-Specific inhibitors-the emergence of a new class of analgesic and anti-inflammatory drugs Clin Rheumatol 19 2000 331 343
125. J.P. Valat, G. Deray, and F. Heloire [Are there any differences in the cardiovascular tolerance between classical NSAIDs and coxibs?] Presse Med 35 Suppl 1 2006 25 34
126. J. An, Y. Sun, M. Fisher, and M.B. Rettig Antitumor effects of bortezomib (PS-341) on primary effusion lymphomas Leukemia 18 2004 1699 1704
127. N.L. Toomey, V.V. Deyev, and C. Wood Induction of a TRAIL-mediated suicide program by interferon alpha in primary effusion lymphoma Oncogene 20 2001 7029 7040
128. K.M. Ansari, Y.M. Sung, G. He, and S.M. Fischer Prostaglandin receptor EP2 is responsible for cyclooxygenase-2 induction by prostaglandin E2 in mouse skin Carcinogenesis 28 2007 2063 2068
129. G. Sarek, S. Kurki, and J. Enback Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas J Clin Invest 117 2007 1019 1028
130. L. Hocqueloux, F. Agbalika, E. Oksenhendler, and J.M. Molina Long-term remission of an AIDS-related primary effusion lymphoma with antiviral therapy Aids 15 2001 280 282
131. M. Luppi, R. Trovato, and P. Barozzi Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir Leukemia 19 2005 473 476
132. T.R. Halfdanarson, S.N. Markovic, U. Kalokhe, and M. Luppi A nonchemotherapy treatment of a primary effusion lymphoma: durable remission after intracavitary cidofovir in HIV negative PEL refractory to chemotherapy Ann Oncol 17 2006 1849 1850
133. A.P. Bhatt, P.M. Bhende, S.H. Sin, D. Roy, D.P. Dittmer, and B. Damania Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas Blood 115 2010 4455 4463
134. T.K. Moyo, K.L. Richards, and B. Damania Use of cidofovir for the treatment of HIV-negative human herpes virus-8-associated primary effusion lymphoma Clin Adv Hematol Oncol 8 2010 372 374
135. S.H. Sin, D. Roy, and L. Wang Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling Blood 109 2007 2165 2173
136. D.P. Dittmer, A.P. Bhatt, and B. Damania Rapalogs in viral cancers Expert Opin Investig Drugs 21 2012 135 138
137. F. Ye, F. Zhou, and R.G. Bedolla Reactive oxygen species hydrogen peroxide mediates Kaposi's sarcoma-associated herpesvirus reactivation from latency PLoS Pathog 7 2011 e1002054
138. H.J. Leung, E.M. Duran, M. Kurtoglu, S. Andreansky, T.J. Lampidis, and E.A. Mesri Activation of the Unfolded Protein Response by 2-Deoxy-D-Glucose Inhibits Kaposi's Sarcoma-Associated Herpesvirus Replication and Gene Expression Antimicrob Agents Chemother 56 2012 5794 5803
139. J.Y. Li, X.Z. Wang, F.L. Chen, J.P. Yu, and H.S. Luo Nimesulide inhibits proliferation via induction of apoptosis and cell cycle arrest in human gastric adenocarcinoma cell line World J Gastroenterol 9 2003 915 920
140. M.M. Bertagnolli, C.J. Eagle, and A.G. Zauber Celecoxib for the prevention of sporadic colorectal adenomas N Engl J Med 355 2006 873 884
141. B. Zhong, X. Cai, and S. Chennamaneni From COX-2 inhibitor nimesulide to potent anti-cancer agent: synthesis, in vitro, in vivo and pharmacokinetic evaluation Eur J Med Chem 47 2012 432 444
142. L.L. Winfield, and F. Payton-Stewart Celecoxib and Bcl-2: emerging possibilities for anticancer drug design Future Med Chem 4 2012 361 383
143. K. Szymanska, and P. Hainaut TP53 and mutations in human cancer Acta Biochim Pol 50 2003 231 238
144. T. Sperka, J. Wang, and K.L. Rudolph DNA damage checkpoints in stem cells, ageing and cancer Nat Rev Mol Cell Biol 13 2012 579 590
145. J. Martin, M.V. St-Pierre, and J.F. Dufour Hit proteins, mitochondria and cancer Biochim Biophys Acta 1807 2011 626 632
146. V. Dehennaut, and D. Leprince Implication of HIC1 (Hypermethylated In Cancer 1) in the DNA damage response Bull Cancer 96 2009 E66 E72
147. R.W. Craig MCL1 provides a window on the role of the BCL2 family in cell proliferation, differentiation and tumorigenesis Leukemia 16 2002 444 454
148. C. Zhao, and X. Bu Promoter methylation of tumor-related genes in gastric carcinogenesis Histol Histopathol 27 2012 1271 1282
149. G.L. Semenza Molecular mechanisms mediating metastasis of hypoxic breast cancer cells Trends Mol Med 18 2012 534 543
150. J.H. Overmeyer, and W.A. Maltese Death pathways triggered by activated Ras in cancer cells Front Biosci 16 2011 1693 1713
151. G. Murphy Tissue inhibitors of metalloproteinases Genome Biol 12 2011 233
152. J. Paredes, J. Figueiredo, and A. Albergaria Epithelial E- and P-cadherins: role and clinical significance in cancer Biochim Biophys Acta 1826 2012 297 311
153. M. Esteller Profiling aberrant DNA methylation in hematologic neoplasms: a view from the tip of the iceberg Clin Immunol 109 2003 80 88
154. Y.C. Liao, and S.H. Lo Deleted in liver cancer-1 (DLC-1): a tumor suppressor not just for liver Int J Biochem Cell Biol 40 2008 843 847
155. P. Sarita Rajender, D. Ramasree, K. Bhargavi, M. Vasavi, and V. Uma Selective inhibition of proteins regulating CDK/cyclin complexes: strategy against cancer-a review J Recept Signal Transduct Res 30 2010 206 213
156. D.I. Smith, Y. Zhu, S. McAvoy, and R. Kuhn Common fragile sites, extremely large genes, neural development and cancer Cancer Lett 232 2006 48 57
157. D.L. Di Bartolo, M. Cannon, and Y.F. Liu KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor Blood 111 2008 4731 4740
158. F.Q. An, N. Compitello, E. Horwitz, M. Sramkoski, E.S. Knudsen, and R. Renne The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus modulates cellular gene expression and protects lymphoid cells from p16 INK4A-induced cell cycle arrest J Biol Chem 280 2005 3862 3874
159. Y.C. Shin, H. Nakamura, and X. Liang Inhibition of the ATM/p53 signal transduction pathway by Kaposi's sarcoma-associated herpesvirus interferon regulatory factor 1 J Virol 80 2006 2257 2266
160. B. Ehlin-Henriksson, F. Mowafi, G. Klein, and A. Nilsson Epstein-Barr virus infection negatively impacts the CXCR4-dependent migration of tonsillar B cells Immunology 117 2006 379 385
161. J. Yuan, E. Cahir-McFarland, B. Zhao, and E. Kieff Virus and cell RNAs expressed during Epstein-Barr virus replication J Virol 80 2006 2548 2565
162. K.L. Fries, W.E. Miller, and N. Raab-Traub Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene J Virol 70 1996 8653 8659
163. T. Choudhuri, S.C. Verma, K. Lan, M. Murakami, and E.S. Robertson The ATM/ATR signaling effector Chk2 is targeted by Epstein-Barr virus nuclear antigen 3C to release the G2/M cell cycle block J Virol 81 2007 6718 6730
164. K. Matsusaka, A. Kaneda, and G. Nagae Classification of Epstein-Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes Cancer Res 71 2011 7187 7197
165. G.H. Kang, S. Lee, and W.H. Kim Epstein-Barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma Am J Pathol 160 2002 787 794
166. C. Man, J. Rosa, and L.T. Lee Latent membrane protein 1 suppresses RASSF1A expression, disrupts microtubule structures and induces chromosomal aberrations in human epithelial cells Oncogene 26 2007 3069 3080
167. R. Sompallae, S. Callegari, S.A. Kamranvar, and M.G. Masucci Transcription profiling of Epstein-Barr virus nuclear antigen (EBNA)-1 expressing cells suggests targeting of chromatin remodeling complexes PLoS One 5 2010 e12052
168. C. Chao, M.J. Silverberg, and O. Martinez-Maza Epstein-Barr virus infection and expression of B-cell oncogenic markers in HIV-related diffuse large B-cell Lymphoma Clin Cancer Res 18 2012 4702 4712
169. A. Polack, K. Hortnagel, and A. Pajic c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1 Proc Natl Acad Sci U S A 93 1996 10411 10416
170. I.K. Ruf, P.W. Rhyne, and H. Yang Epstein-barr virus regulates c-MYC, apoptosis, and tumorigenicity in Burkitt lymphoma Mol Cell Biol 19 1999 1651 1660
171. I.K. Ruf, P.W. Rhyne, and H. Yang EBV regulates c-MYC, apoptosis, and tumorigenicity in Burkitt's lymphoma Curr Top Microbiol Immunol 258 2001 153 160
172. J.L. Ryan, R.J. Jones, and S.C. Kenney Epstein-Barr virus-specific methylation of human genes in gastric cancer cells Infect Agent Cancer 5 2010 27
173. T.J. Seng, J.S. Low, and H. Li The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation Oncogene 26 2007 934 944
174. T.M. Chang, and W.C. Hung Transcriptional repression of TWIST1 gene by Prospero-related homeobox 1 inhibits invasiveness of hepatocellular carcinoma cells FEBS Lett 586 2012 3746 3752
175. Y. Dai, Y. Tang, and F. He Screening and functional analysis of differentially expressed genes in EBV-transformed lymphoblasts Virol J 9 2012 77
176. J.L. Kenney, M.E. Guinness, M. Reiss, and J. Lacy Antisense to the Epstein-Barr virus (EBV)-encoded latent membrane protein 1 (LMP-1) sensitizes EBV-immortalized B cells to transforming growth factor-beta and chemotherapeutic agents Int J Cancer 91 2001 89 98
177. B.S. Lee, S.H. Lee, P. Feng, H. Chang, N.H. Cho, and J.U. Jung Characterization of the Kaposi's sarcoma-associated herpesvirus K1 signalosome J Virol 79 2005 12173 12184
178. J. Kim, H.S. Lee, S.I. Bae, Y.M. Lee, and W.H. Kim Silencing and CpG island methylation of GSTP1 is rare in ordinary gastric carcinomas but common in Epstein-Barr virus-associated gastric carcinomas Anticancer Res 25 2005 4013 4019
179. S. Wang, M. Rowe, and E. Lundgren Expression of the Epstein Barr virus transforming protein LMP1 causes a rapid and transient stimulation of the Bcl-2 homologue Mcl-1 levels in B-cell lines Cancer Res 56 1996 4610 4613
180. S.H. Hutajulu, S.R. Indrasari, and L.P. Indrawati Epigenetic markers for early detection of nasopharyngeal carcinoma in a high risk population Mol Cancer 10 2012 48
181. M. Lasa, K.R. Mahtani, A. Finch, G. Brewer, J. Saklatvala, and A.R. Clark Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade Mol Cell Biol 20 2000 4265 4274
182. C. McCormick, and D. Ganem The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs Science 307 2005 739 741
183. M. Pearce, S. Matsumura, and A.C. Wilson Transcripts encoding K12, v-FLIP, v-cyclin, and the microRNA cluster of Kaposi's sarcoma-associated herpesvirus originate from a common promoter J Virol 79 2005 14457 14464
184. M.R. Staudt, and D.P. Dittmer Promoter switching allows simultaneous transcription of LANA and K14/vGPCR of Kaposi's sarcoma-associated herpesvirus Virology 350 2006 192 205
185. J.H. Jeong, J. Orvis, J.W. Kim, C.P. McMurtrey, R. Renne, and D.P. Dittmer Regulation and autoregulation of the promoter for the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus J Biol Chem 279 2004 16822 16831
186. W. Stedman, H. Kang, S. Lin, J.L. Kissil, M.S. Bartolomei, and P.M. Lieberman Cohesins localize with CTCF at the KSHV latency control region and at cellular c-myc and H19/Igf2 insulators Embo J 27 2008 654 666
187. J.L. Barclay, S.T. Anderson, M.J. Waters, and J.D. Curlewis Characterization of the SOCS3 promoter response to prostaglandin E2 in T47D cells Mol Endocrinol 21 2007 2516 2528
188. R.G. Jenner, K. Maillard, and N. Cattini Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile Proc Natl Acad Sci U S A 100 2003 10399 10404
189. M.D. Bass, M.R. Morgan, and M.J. Humphries Syndecans shed their reputation as inert molecules Sci Signal 2 2009 pe18
190. F.C. Campbell, H. Xu, M. El-Tanani, P. Crowe, and V. Bingham The yin and yang of vitamin D receptor (VDR) signaling in neoplastic progression: operational networks and tissue-specific growth control Biochem Pharmacol 79 2010 1 9
191. A.S. Verkman, M. Hara-Chikuma, and M.C. Papadopoulos Aquaporins-new players in cancer biology J Mol Med 86 2008 523 529
192. R.T. Greenlee, M.B. Hill-Harmon, T. Murray, and M. Thun Cancer statistics, 2001 CA Cancer J Clin 51 2001 15 36
193. S. Chakraborty, M.V. Veettil, and B. Chandran Kaposi's Sarcoma Associated Herpesvirus Entry into Target Cells Front Microbiol 3 2012 6
194. S. Chakraborty, M. ValiyaVeettil, S. Sadagopan, N. Paudel, and B. Chandran c-Cbl-mediated selective virus-receptor translocations into lipid rafts regulate productive Kaposi's sarcoma-associated herpesvirus infection in endothelial cells J Virol 85 2011 12410 12430
195. S. Chakraborty, M.V. Veettil, V. Bottero, and B. Chandran Kaposi's sarcoma-associated herpesvirus interacts with EphrinA2 receptor to amplify signaling essential for productive infection Proc Natl Acad Sci U S A 109 2012 E1163 E1172
196. N. Kerur, M.V. Veettil, and N. Sharma-Walia Characterization of entry and infection of monocytic THP-1 cells by Kaposi's sarcoma associated herpesvirus (KSHV): role of heparan sulfate, DC-SIGN, integrins and signaling Virology 406 2010 103 116
197. H. Raghu, N. Sharma-Walia, M.V. Veettil, S. Sadagopan, and B. Chandran Kaposi's sarcoma-associated herpesvirus utilizes an actin polymerization- dependent macropinocytic pathway to enter human dermal microvascular endothelial and human umbilical vein endothelial cells J Virol 83 2009 4895 4911
198. M.V. Veettil, S. Sadagopan, and N. Sharma-Walia Kaposi's sarcoma-associated herpesvirus forms a multimolecular complex of integrins (alphaVbeta5, alphaVbeta3, and alpha3beta1) and CD98-xCT during infection of human dermal microvascular endothelial cells, and CD98-xCT is essential for the postentry stage of infection J Virol 82 2008 12126 12144